Indium_(111In)_altumomab_pentetate

Indium (111In) altumomab pentetate

Indium (111In) altumomab pentetate

Add article description

Indium (111In) altumomab pentetate (INN) (USP, indium In 111 altumomab pentetate; trade name Hybri-ceaker) is a mouse monoclonal antibody linked to pentetate which acts as a chelating agent for the radioisotope indium-111. The drug is used for the diagnosis of colorectal cancer[1][2] but has not been approved for use.[3]

Quick Facts Monoclonal antibody, Type ...

References

  1. [1]
    "lnternational Nonproprietary Names for Pharmaceutical Substances" (PDF). WHO Drug Information. 7 (3). 1993. Archived from the original (PDF) on 2012-02-19. Retrieved 2009-09-22.
  2. [2]
    "Cumulartive [sic] Designated Products List". U.S. Food and Drug Administration. Archived from the original on 26 October 2012 – via Scribd Inc.
  3. [3]
    Kim EE (2001). "Radioimmunodetection of Cancer". Targeted Molecular Imaging in Oncology. New York, NY: Springer. pp. 88-101 (92). ISBN 9780387950280.


Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

Stub icon

This nuclear medicine article is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Indium_(111In)_altumomab_pentetate, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.